The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore

per Hashan, Hajed, Aljuffali, Ibrahim, Patel, Prisha, Walker, Stuart
Publicat a Pharmaceut Med (2015)

The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore

per Haqaish, Wesal Salem Al, Obeidat, Hayel, Patel, Prisha, Walker, Stuart
Publicat a Pharmaceut Med (2016)

An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017–2018 using the OpERA methodology

per Liberti, Lawrence, Extavour, Rian Marie, Patel, Prisha, McAuslane, Neil
Publicat a J Pharm Policy Pract (2020)

Use of the Certificate for Pharmaceutical Products (CPP) in 18 Maturing Pharmaceutical Markets: Comparing Agency Guidelines with Company Practice

per Rodier, Céline, Bujar, Magda, McAuslane, Neil, Patel, Prisha, Liberti, Lawrence
Publicat a Ther Innov Regul Sci (2020)

An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology

per Sani, Noraisyah Mohd, McAuslane, Neil, Kasbon, Siti Hidayah, Ahmad, Rosilawati, Yusof, Faridah Aryani Md., Patel, Prisha
Publicat a Ther Innov Regul Sci (2020)

Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology

per Sani, Noraisyah Mohd, McAuslane, Neil, Kasbon, Siti Hidayah, Ahmad, Rosilawati, Yusof, Faridah Aryani Md., Patel, Prisha
Publicat a Ther Innov Regul Sci (2020)

A Baseline Analysis of Regulatory Review Timelines for ANVISA: 2013–2016

per Patel, Prisha, Cerqueira, Daniela Marreco, Santos, Gustavo Mendes Lima, de Lima Soares, Renata, Sousa, Varley Dias, Liberti, Lawrence, McAuslane, Neil
Publicat a Ther Innov Regul Sci (2020)